chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received 2nd dose on 5/22/2021 at pharmacy. On Sunday 5/23/2021, I felt sick, had flu like symptoms,  joints in hands were swollen, hot and red.  I was in alot of pain and called my regular doctor. He couldnt  see me until 6/9/2021. It spread to my toes, knee joint, hip joint. On 6/9/2021, doctor said I have Rheumatoid Arthritis and did lab tests to confirm.
No adverse reaction. Dose was from an expired vial given by accident. Dose given 9/24/2021 which the vials expiration date was 9/19/2021. This was the 1st dose in the Moderna series of 2.
some patients feel "a little peeked"; This case was reported by a consumer and described the occurrence of feeling unwell in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was unknown.   It was unknown if the reporter considered the feeling unwell to be related to Shingrix.  Additional details were provided as follows: The age at vaccination not reported. The reporter's physician stated that, the some patients felt a little peeked the next day after vaccination. The patient believed in vaccinations, but if asked by friends and acquaintances, will provide an honest and unflattering appraisal of his or her experience and understand it was his or her immune response working, but would suggest research to discover a way to mitigate side effects. Otherwise, there would be reluctance from the public to acquire this vaccine as it was reputation spreads. This case was linked with US2021AMR028707, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR028707:same reporter
This spontaneous report was received from a medical assistant who reported that on an unknown date, improperly stored doses of PNEUMOVAX 23, (lot # N003997, expiry date 20-OCT-2018) had been administered to unspecified patients. The numbers of doses were unspecified. There was a previous temperature excursion for the vaccines of 47°F to 77°F for 45 minutes. Then, the vaccines had other temperature excursions of 47°F to 77°F for 4 hours. No data logger involved. No adverse effects were reported. This is one of three reports from the same reporter source, (linked to MARRS # 1706USA008963 and 1706USA009319). Additional information has been requested. Sender's Comments: US-009507513-1706USA008963: US-009507513-1706USA009319.
Approximately 8 hours after the vaccine was administered, I began to experience, fatigue, joint pain/soreness, slight fever, chills, headache, slight dizziness and mild shortness of breath. I have experienced similar symptoms after receiving previous doses. Based on this previous experience, I expect the symptoms to alleviate by vaccination time + 24 hours.
booster she had a reaction a week after the shot; Both of her arms have a rash.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (booster she had a reaction a week after the shot) and RASH (Both of her arms have a rash.) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029H21B, 007C21A and 028A21A) for COVID-19 vaccination.     Concomitant products included SIMVASTATIN, LOSARTAN and BUPROPION HYDROCHLORIDE (BUP) for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced VACCINATION COMPLICATION (booster she had a reaction a week after the shot) and RASH (Both of her arms have a rash.). At the time of the report, VACCINATION COMPLICATION (booster she had a reaction a week after the shot) and RASH (Both of her arms have a rash.) outcome was unknown.            No treatment drug information was provided   This case was linked to MOD-2021-433312, MOD-2021-433166 (Patient Link).
p/1st set of vax pt reportedly inconsolable x 3-6 hrs, temp to 101; did give APAP; no other treatment;
Just a little woozy 5 minutes after the vaccine. Took another 5 minutes to pass; This is a spontaneous report from a contactable consumer (patient). A 50-Year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL8982) via unknown route of administration on 23Feb2021 11:45 AM as single dose in left arm for COVID-19 immunization at Hospital. Medical history included known allergies to Wasps. Concomitant medications were not reported. Patient was not pregnant at the time of vaccination. No covid prior vaccination. No other vaccine in four weeks. The patient experienced little woozy 5 minutes after the vaccine on 23Feb2021 11:50 AM. Took another 5 minutes to pass. No treatment to adverse event. No covid tested post vaccination. Outcome of event was recovered on 23Feb2021.  No follow-up attempts are possible. No further information is expected.
Headache, Myalgia, Arthralgia, Fever, Tachycardia, Chills, lasted 24 hours Narrative:
Headache, Sedation, Myalgia, Arthralgia, Fever, NauseaVomiting, Chills, pain at injection site Narrative:
Generalized Urticaria.  Treated with IM Dexamethasone and oral Benadryl at the emergency room on 11/11/21.  Office visit to recheck on 11/12/21.  On continued Benadryl and oral prednisolone.  Urticaria continues.  No other problems aside from the rash.
Pt came to pharmacy and said she was experiencing pain and rash at injection site so pharmacist on duty recommended BENADRYL and ibuprofen over the counter.
Pt called RN to car. He states he is feeling his eyes swell and some tightness in his chest. SpO2=95%, no wheeze on auscultation. Pt reports history of asthma and allergies. 25mg Benadryl PO given. Symptoms resolved. Pt observed 30 minutes by RN and MD and sent home with emergency precautions. Pt and wife state understanding.
fever; body ache; flu-like symptoms; This is a spontaneous report from a contactable other hcp (Nurse Practitioner). A 49-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on 30Jun2021 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. Medical history included covid-19 from Jun2020 to an unknown date. The patient's concomitant medications were not reported. On an unknown date in 2021, the patient experienced fever, body ache, flu-like symptoms. It was reported that The Caller wants to check what to do with his patient since his patient got tested positive last Jun2020 and got the 1st dose of the vaccine last 30Jun2021. His Patient had a significant reaction like lymph nodes, fever, body ache and flu-like symptoms. His patient worries over the myocarditis and pericarditis side effects. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on Jun2020. The outcome for all events was unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
I had minimal reaction to the 1st dose, slightly sore arm at injection site for 3 or 4 days. 2nd dose, I was feeling off by 3:30pm, mild headache and extremely tired. By 5 I was exhausted, and paranoid about a work situation, paranoia is not part of my normal state of being. By 6pm my left upper arm was very  painful from shoulder to elbow. Took aspirin and went to bed at 7pm.  Woke at 8am Friday with mild headache an very tired, by 10am was back in bed, slept 4 hours, Repeated the Friday pattern for 2 more days. Monday the extreme tiredness and arm pain abated. Tuesday, the paranoia abated. Now just Brain Fogged.
Information has been received from a nurse concerning a female (age was not reported) who in October 2006, was vaccinated intramuscularly with the first 0.5 ml dose of GARDASIL vaccine (yeast) and subsequently determined to be pregnant. During the patient's pregnancy she developed pyelonephritis. The patient recovered from pyelonephritis prior to delivery and delivered a healthy infant without complication. Patient did receive unspecified medical attention. Additional information has been requested.
Subject in pneumococcal vaccine trial, with severe COPD died of unknown cause on 10/14/09. Vaccination took place 10/07/07. According to physician the relationship is 'unlikely'.
Infant had swelling of hands and feet starting within 24 hours of vaccinations.  Feet were swollen more than hands.  Feet also had purple and red discoloration.  This was impressive discoloration with visible shifting of red and purple areas as the child was observed.  The infant also had fever up to 101 on the day the symptoms started.  Fever was not persistent (lasted less than 24 hours).   Otherwise, the infant was well appearing, happy and feeding well.  When child was seen 3 days after the start of symptoms, hands appeared normal.  The feet remained a little edematous although improved from initial presentation.  Color of feet at the time of the follow up exam was normal.
Starting (1/08/19), started with redness, swelling, tenderness, pruritis, surrounding injection site in L arm s/p vaccines. Received 11 year old vaccines on 1/08/19. No fevers, has no change in ROM. No shortness of breath, cough. Received MC4 and Tdap in the same location (L upper extremity) and HPV on the (R)-Has had no signs of anaphylaxis. Avoid touching, scratching affected area-OK to use cool compresses-Take antihistamine as prescribed for itching-F/U in 2 days to ensure improvement of symptoms-Education: Education provided considers health literacy level. Patient/caregiver states/demonstrates understanding of the assessment, plan and health education provided. He is to schedule a follow-up visit for Recheck/Follow-Up 2  Days.
Patient Passed out shortly after being vaccinated, was standing at pharmacy counter and collapsed, staff called 911 and the patient was taken to hospital Medical Center emergency room in ambulance
10/04/04 woke up with rash and swollen right knee front and back.10/05/04 Both knees swollen and had a fever. Saw the Dr. prescribed ice packs and 600mg ibuprofen.  10/06/04 left elbow,wrist, and fingers swollen. 10/12/04 right wrist, and fingers swollen.  Knees got better with treatment after 3 days each.  Rash lasted 3 days.  Both hands and wrist have not yet recovered. I could not walk well for 4 days and missed 4 days of work.
mark on the arm with sides of a quarter with pus/pus bump; Itchy rash on buttock / rash on the top of the buttocks; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchy rash on buttock / rash on the top of the buttocks) and PUSTULE (mark on the arm with sides of a quarter with pus/pus bump) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included Herpes infection.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced RASH PRURITIC (Itchy rash on buttock / rash on the top of the buttocks). On 25-Mar-2021, the patient experienced PUSTULE (mark on the arm with sides of a quarter with pus/pus bump). At the time of the report, RASH PRURITIC (Itchy rash on buttock / rash on the top of the buttocks) and PUSTULE (mark on the arm with sides of a quarter with pus/pus bump) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported.  The patient states that she was given antibiotics to treat the rash with pus on her arm and states that this event as resolved as per her follow up on 1-Jul-21.   Most recent FOLLOW-UP information incorporated above includes: On 25-Mar-2021: Source doc appended On 01-Jul-2021: Significant followup appended, pictures of arm were emailed. On 24-Jul-2021: Non-significant follow-up received.
Pt. Received vaccines in office. When in parking lot, fainted. Mother able to hold up. No injuries noted! Responded immediately.
Approx. 15 minutes after receiving vaccine I felt fuzzy-headed and had a bad taste in my mouth. Felt somewhat dizzy after getting home. That evening I got up to use the bathroom and could hardly walk. Dizzy off and on for week.
This spontaneous report as received from a nurse practitioner refers to multiple patients of unknown age and gender. The patients' medical history, current conditions and concomitant medications were unknown. On unknown dates the patients were vaccinated with improperly stored PEDVAXHIB (dose and route were not reported) lot # M032147 and expiry date: 14-APR-2019, lot # M025192 and expiry date: 21-MAR-2019 for prophylaxis. The call was because of a data logger. No adverse events were reported. There was no product quality complaint involved. No further information was provided. This is one of the several reports from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1612USA007518: US-009507513-1612USA007519: US-009507513-1612USA001375.
elevated blood pressure; I got a severe headache, it was really bad; Expired vaccine used; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (elevated blood pressure), HEADACHE (I got a severe headache, it was really bad) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037F21A, 028L20A and 012L20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included HYDRALAZINE and AMLODIPINE for an unknown indication.On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form.On 10-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced HYPERTENSION (elevated blood pressure) and HEADACHE (I got a severe headache, it was really bad). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. On 10-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. At the time of the report, HYPERTENSION (elevated blood pressure) and HEADACHE (I got a severe headache, it was really bad) was resolving.DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available):On an unknown date, Blood pressure measurement: 157-105 (High) 157-105 (high lowest was 139-94).For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
8 days after vaccination - stroke/full right side of body paralyzed - clot buster drug at ER
Severe head ache began approx. 2- 3 hours after injection. Followed by fever of102 degrees. Day two fever persisted, nauseous, weakness. Spent entire week with high fever, averaging 101-102 degrees. Day 4 severe diarrhea and vomited. Fever finally broke on  4/11. Currently have heavy chest, cough and weakness.   Have spent entire week in bed using Tylenol only.
With the first 3 doses she usually gets a bump on the injection site; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient received BNT162b2 (BNT162B2), on 21Oct2021 as dose 2, single (Lot number: FF2593) at the age of 57 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Autoimmune disease" (unspecified if ongoing); "hard to walk" (unspecified if ongoing); "her hands because they go numb" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Prednisone, reaction(s): "inflammation disease". Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot Number: FF8839, Anatomical location: Left arm), administration date: 29Sep2021, when the patient was 56-year-old, for COVID-19 immunization, reaction(s): "With the first 3 doses she usually gets a bump on the injection site". The following information was reported: VACCINATION SITE MASS (non-serious), outcome "not recovered", described as "With the first 3 doses she usually gets a bump on the injection site". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: Additional Information: It was reported that, the patient had attacks where it was hard to walk and use her hands because they go numb. The patient Sed rate and C-reactive proteins were high. The patient was told it was inflammation disease. She was on prednisone for 2 years. Had test after test. Does not know the name of her disease. The patient was not on Prednisone anymore. Does not know if the prednisone helped whatever it was as she was able to walk and use her hands now. The patient did not receive other vaccines within four weeks prior to COVID vaccine.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201268928 same patient, different dose, similar report from same reporter;
Started with extreme chills in the evening  and progressed to chills with tiredness and overall aching body lasting about 36 hours from onset.
Synovitis on right and left hand finger knuckles and wrist joints with evident damaged to the joints soft tissues with the formation of lumps the size of petit poi?s on both of the joints described above. Joint damaged evolved in a matter of four days. Tendinitis on all tendons on right and left forearms.  between wrists and elbow. Excruciating pain on my hands and forearms. I have dealt with all kind of joint issues during my 15 years battle with rheumatoid arthritis but I have never seen joint damaged developed in such a short period of time. My concern is what other soft tissue in my body is being affected. ?????
Itchy, redness, bad swelling, warm to touch, extremely sensitive, pain with some movements, 2.5 inch circumference of redness, 5.5 inch circumference of hard swelling
Patient came to pharmacy today 3/30/21 with his wife so she could get shot. He complained of over the past several days high fevers, chills, vomiting, stomach ache and general malaise. While here with wife, patient started having extreme chills and shivering and 911 was called. Paramedics came and advised patient it could be after effects of vaccine or Gastro-intestinal bug but patient did not go to the hospital.
Headache and feeling poor all over with a full body ache. Along with fatigue and weakness. This lasted 2 days.
I RECEIVED THE SHOT LATE MORNING TO MY UPPER LEFT ARM AND DID NOT EXPERIENCE ANY PAIN AT ALL. I WAS WORKING AT A JOB WHERE I HAVE LIMITED PHYSICAL ACTIVITY. AFTER ABOUT AN HOUR I EXPERIENCED NUMBNESS AND PAIN IN MY UPPER ARM IN THE PERIMETER AROUND WHERE I RECEIVED THE SHOT.  THEN MY LOWER SPINE AREA HURT, AS THOUGH I HAD HIT IT (BUT I HADN'T). AT THE SAME TIME I EXPERIENCED PAIN AND NUMBNESS IN AN AREA ON MY UPPER LEFT LEG.  BY THE END OF THE DAY I WAS GENERALLY ILL AND LEFT ARM, LOWER SPINE AND UPPER LEFT LEG WERE VERY PAINFUL AND NUMB TO THE TOUCH.  ADDITIONALLY, MY HEART WAS "FLUTTERING" INTERMITTENTLY.  AFTER TWO DAYS. I WAS UNABLE TO TOLERATE THE PAIN AND RESTED IN BED THAT DAY.  BY THIS TIME, THE AREA OF MY LEG THAT WAS NUMB HAD PETECHIA (RASH).  IT WAS TOO PAINFUL FOR ME TO BRING MY ARM THROUGH RANGE OF MOTION.  OVER THE FOLLOWING WEEKS, MY PAIN AND NUMBNESS SUBSIDED, THE SPOT ON MY LEG NOT HURTING AND RETURNING FEELING FIRST.  THIS IS THE FIRST WEEK THAT I HAVE NOT HAD PAIN IN MY ARM AND I MOST OF THE LACK OF ABILITY TO FEEL TOUCH HAS SUBSIDED.
This spontaneous report as received from a registered nurse refers to a 69 years old female patient with asthma, chronic obstructive pulmonary disease(COPD), hypothyroidism, cirrhosis of liver, chronic kidney disease and codeine allergy. The patient's medical history included liver disease and hepatitis C. The patient was vaccinated with a dose of 0.5 ml PNEUMOVAX23 (lot number reported as H018441, exp:28-FEB-2014) intramuscularly into left arm on 14-JAN-2013. No other co-suspects were reported. Concomitant medications included SYNTHROID, NITROSTAT, INDERAL, PROAIR, vitamin D (unspecified), FLONASE and albuterol nebulizer. On an unspecified date of 2013 the patient experience redness and swelling of arm at injection site, pain and bruising of her left arm at injection site and headache. The patient had visited office for medical attention and was treated with ice packs to arm. At the time of the report, the outcome of the patient was unknown. The relatedness for the adverse events was unknown for Pneumovax23. No lab diagnostic studies performed. This is one of several reports received from same source. Additional information has been requested.
This spontaneous report as received from a Certified Medical Assistant (CMA) refers to one of two (case # 1508USA007834) unspecified no pregnant female patient of estimated age "about 11 or 12 years of age. The patient concurrent conditions, medical history and allergies were not provided. On an unknown date, the patient was vaccinated whether with dose of GARDASIL or GARDASIL 9, (strength, dose, frequency, route, anatomical location, lot number and expiration date were not reported). Concomitant therapies were not provided. On an unknown date, after the vaccination, the patient vomited and sought medical attention through office visit on an unknown date. There was no treatment administered following the adverse event and the patient did not return to the office as a follow up for the adverse events. The outcome of vomiting was reported as recovered on an unknown date. The relatedness between vomiting and therapy with GARDASIL and GARDASIL 9 was not reported. Additional information has been requested.
4/9/2021 Had Covid Janssen Vaccination 8/3/2021 Asymptomatic,  POC testing, tested Positive for Covid 8/14/21 Potential to return to work
Patient presented to the ED and was subsequently admitted to the hospital on 2/15/21. Patient presented to the ED on 2/19/21. Patient presented to the ED and was subsequently hospitalized on 3/1/21. These visits all occurred within 6 weeks of receiving COVID vaccination.
No additional AE reported; Expired dose of MMR II was administered to patient; MMR II vaccine was administered intramuscularly; This spontaneous report was received from a physician and refers to a 34-year-old female patient. No concurrent conditions, medical history and concomitant medications were reported.  On 08-DEC-2021, the patient was vaccinated at physician office with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (rHA)(M-M-R II) (first dose, intramuscularly, lot # S032825, expiration date 16-OCT-2021)(exact dose unknown) for prophylaxis (Expired product administered, Incorrect route of product administration). Vaccine was prepared with diluent which had expiration date of 10-JUL-2022. Mistake made because looked at the expiration date for diluent and revealed after administration of vaccine.  The vaccine was used according to leaflet, operator of vaccine was healthcare professional and was trained. The patient did not experience any adverse events (response after administration reported as normal). No treatment was prescribed for the event.
Pt had chest pain and high blood pressure.  Blood pressure did not go down medics were called. Pt care was turned over to  FD. PT was transported to the hospital